These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 509789)

  • 1. Comparison of the effects of lactate and acetate on clinical peritoneal clearances.
    Rubin J; Nolph KD; Arfaania D; Wiegman DL; Miller FN; Harris PD
    Clin Nephrol; 1979 Oct; 12(4):145-7. PubMed ID: 509789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal clearances with three types of commerically available peritoneal dialysis solutions. Effects of pH adjustment and intraperitoneal nitroprusside.
    Nolph KD; Rubin J; Wiegman DL; Harris PD; Miller FN
    Nephron; 1979; 24(1):34-40. PubMed ID: 40148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Net ultrafiltration volume (nUFV) during IPD with acetate or lactate dialysis solutions.
    Grzegorzewska AE; Uchman G
    Adv Perit Dial; 1990; 6():19-22. PubMed ID: 1982806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transperitoneal solute movement in children.
    Gruskin AB; Rosenblum H; Baluarte HJ; Morgenstern BZ; Polinsky MS; Perlman SA
    Kidney Int Suppl; 1983 Nov; 15():S95-100. PubMed ID: 6584681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequacy of solute and water removal in children treated with nightly intermittent peritoneal dialysis.
    Edefonti A; Picca M; Ghio L; Bassi S; Cattarelli D; Leccese V
    Adv Perit Dial; 1992; 8():402-5. PubMed ID: 1361833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. V. Usefulness of selected parameters of peritoneal transfer for evaluating the effectiveness of intermittent peritoneal dialysis].
    Grzegorzewska A
    Przegl Lek; 1989; 46(5):440-7. PubMed ID: 2772244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of peritoneal ultrafiltration capacity in children undergoing peritoneal dialysis.
    Drachman R; Niaudet P; Gagnadoux MF; Broyer M
    Int J Pediatr Nephrol; 1985; 6(1):35-40. PubMed ID: 3997371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of continuous ambulatory peritoneal dialysis (CAPD) with four exchanges per day.
    Twardowski Z; Ksiazek A; Majdan M; Janicka L; Bocheńska-Nowacka E; Sokołowska G; Gutka A; Zbikowska A
    Clin Nephrol; 1981 Mar; 15(3):119-30. PubMed ID: 7273487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of intraperitoneal vasodilators on peritoneal clearances.
    Nolph KD; Ghods AJ; Van Stone J; Brown PA
    Trans Am Soc Artif Intern Organs; 1976; 22():586-94. PubMed ID: 951875
    [No Abstract]   [Full Text] [Related]  

  • 10. Bi-directional permeability of the human peritoneum to middle molecules.
    Babb AL; Johansen PJ; Strand MJ; Tenckhoff H; Scribner BH
    Proc Eur Dial Transplant Assoc; 1973; 10(0):247-62. PubMed ID: 4802410
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased peritoneal solute transport in diabetic peritoneal dialysis patients.
    Lin JJ; Wadhwa NK; Suh H; Cabralda T; Patlak CS
    Adv Perit Dial; 1995; 11():63-6. PubMed ID: 8534740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clearance of urea, creatinine, beta 2 microglobulin and the loss of proteins in treatment with continuous ambulatory peritoneal dialysis].
    Kozjak D; Prejac M; Jeren-Struić B; Gudelj J; Kovarbasić B
    Lijec Vjesn; 1982; 104(11-12):532-5. PubMed ID: 6764943
    [No Abstract]   [Full Text] [Related]  

  • 13. Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis.
    Rubin J; Nolph K; Arfania D; Brown P; Prowant B
    Kidney Int; 1979 Nov; 16(5):619-23. PubMed ID: 548605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems of membranes involved in peritoneal dialysis.
    Rubin J; Jones Q; Planch A; Stanek K
    J Lab Clin Med; 1987 Oct; 110(4):448-53. PubMed ID: 3655524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of calcium antagonists on the peritoneal membrane in patients on CAPD.
    Vargemezis V; Pasadakis P; Thodis E
    Adv Perit Dial; 1989; 5():8-11. PubMed ID: 2577433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
    Grzegorzewska AE; Leander M; Mariak I
    Adv Perit Dial; 2002; 18():33-9. PubMed ID: 12402583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indoprofen in chronic intermittent peritoneal dialysis: effects in the clearance of small molecules and protein loss].
    García-Ortiz R; Campos G; Silva G; Gómez M; Uribe C; Herrera O
    Rev Med Chil; 1989 May; 117(5):528-33. PubMed ID: 2519164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperosmolality, acetate, and lactate: dilatory factors during peritoneal dialysis.
    Miller FN; Nolph KD; Joshua IG; Wiegman DL; Harris PD; Andersen DB
    Kidney Int; 1981 Sep; 20(3):397-402. PubMed ID: 7300129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher KT/V urea associated with greater protein catabolic rate and dietary protein intake in children treated with CCPD compared to CAPD. Mid-European Pediatric CPD Study Group (MPCS).
    Schaefer F; Wolf S; Klaus G; Langenbeck D; Mehls O
    Adv Perit Dial; 1994; 10():310-4. PubMed ID: 7999855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal dialysis solutions.
    Gault MH
    Can Med Assoc J; 1973 Feb; 108(3):325-7. PubMed ID: 4691094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.